Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Symptom interference negatively affects quality of life in women with ovarian cancer.

A new genetic region, 17q21.31, is linked to higher ovarian cancer risk.

Some medications can improve skin conditions, while lifestyle factors like smoking and drinking may worsen them; treatments like monoclonal antibodies and imiquimod cream show promise for certain skin diseases.

Nano-sized plant-based chemicals could improve cervical cancer treatment by being more effective and causing fewer side effects than current methods.

REV7 is crucial for genome stability and cancer treatment, making it a potential target for therapy.

Certain genes can predict how well breast cancer patients respond to chemotherapy.

New markers can detect tumors, aid drug delivery, and treat cancer effectively and safely.

Exercise-induced particles can slow breast cancer growth by boosting immune response.

Pegylated liposomal doxorubicin is as effective as conventional doxorubicin but causes fewer heart problems and side effects.

Nurses are crucial in managing chemotherapy side effects for ovarian cancer patients to improve their quality of life.

Sorafenib and Platycladus orientalis leaf extract together effectively suppress cervical cancer cell growth.

The Li-Pa/Ca and Do/Ca chemotherapy regimens for serous ovarian cancer showed better short-term and long-term results than the Pa/Ca regimen.

The document concludes that early and personalized treatment for PCOS in adolescents is crucial to manage symptoms and prevent long-term health issues.

Serenoa repens (saw palmetto) may cause side effects like hot flashes in children and needs more research for safety in pediatric use.

Women with PCOS have higher oxidative stress and hormone imbalances, suggesting managing oxidative stress could help.

The woman's rare combination of diseases suggests an unknown factor may predispose individuals to multiple endocrine diseases.

19.7% of Afro-Caribbean women in Tobago have PCOS.

The new drug carriers show promise for better targeting and treating ovarian cancer.

Young female athletes should be informed about health risks like menstrual issues and bone problems from excessive sports.

Oncologists should better understand the unique impact of hair loss on Black breast cancer patients to offer more compassionate care.

Frequent use of chemical hair relaxers may increase endometrial cancer risk in Black women.

Gut bacteria affect female reproductive health and may help diagnose and treat related diseases.

Melatonin affects many body functions beyond sleep by interacting with specific receptors in various tissues.

Testosterone therapy seems safe for short-term use in postmenopausal women with low sexual desire, but more research on long-term effects is needed.

Testosterone therapy can safely and effectively treat symptoms like low libido and fatigue in women, especially after menopause.

A postmenopausal woman's excessive hair growth and hair loss were due to a non-cancerous ovarian condition, treated successfully with surgery.

Diagnosing and treating PCOS is complex due to differing criteria and requires a team approach.

The document concludes that managing PCOS involves lifestyle changes, medication, and monitoring for associated health risks.

Taking spironolactone doesn't increase the chance of breast cancer coming back.

Women with PCOS have a higher risk of diabetes, heart problems, certain cancers, and mental health issues, but early treatment can help manage these risks.